Direkt zum Inhalt
Merck
  • Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis.

Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis.

Surgical laparoscopy, endoscopy & percutaneous techniques (2013-02-07)
Si-Jia Wu, Xian-Ze Xiong, Yi-Xin Lin, Nan-Sheng Cheng
ZUSAMMENFASSUNG

Our purpose was to assess the prophylactic antiemetic effects of ondansetron versus granisetron for laparoscopic cholecystectomy. We searched Medline, Cochrane Central Register of Controlled Trials, PubMed, Embase, Science Citation Index Expanded, Foreign Medical Journal Full-Text Service, China National Knowledge Infrastructure Whole Article Database, Chinese Biomedical Database, and the Google Scholar. We calculated the risk ratio (RR) with 95% confidence interval (CI) for dichotomous data. The χ(2) test and I(2) value were used to assess heterogeneity. The merged early incidence of postoperative nausea and vomiting (PONV) in ondansetron group (42.9%) was higher than granisetron group (34.3%) (RR = 1.25, 95% CI, 0.82-1.92, P=0.31, I(2) = 48%). The merged total incidence of PONV in ondansetron group (38.7%) was higher than granisetron group (34.2%) (RR = 1.13, 95% CI, 0.82-1.56, P = 0.46, I(2) = 39%), although these differences were not statistically significant. Ondansetron is equivalent to granisetron for preventing early and total incidence of PONV after laparoscopic cholecystectomy.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ondansetron -hydrochlorid Dihydrat, ≥98% (HPLC), powder
Supelco
Ondansetron-Hydrochlorid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Granisetron -hydrochlorid, ≥98% (HPLC), solid
Ondansetron -hydrochlorid Dihydrat, European Pharmacopoeia (EP) Reference Standard
Granisetron -hydrochlorid, European Pharmacopoeia (EP) Reference Standard
Ondansetron für die LC-Systemeignung, European Pharmacopoeia (EP) Reference Standard
Ondansetron für die TLC-Systemeignung, European Pharmacopoeia (EP) Reference Standard